Petros Pharmaceuticals's total assets for Q3 2024 were $20.69M, a decrease of -17.78% from the previous quarter. PTPI total liabilities were $17.58M for the fiscal quarter, a 9.97% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.